Defense Business Confidence Report Q2 2014

Summary

Defense Business Confidence Report Q2 2014 is a new report by Strategic Defence Intelligence that globally analyzes industry opinions on the latest economic and customer issues, and their impact on investment decisions and growth prospects within the defense industry. This report also examines executive opinion about the current and future state of the economy and its retrospective effect on the industry. Furthermore, it analyzes the likely effect of supplier price changes, sales performance, and staff headcount within the industry over the next six months. In addition, it provides an overview of the key priorities, threats, and opportunities for the global defense industry over the next six months. Moreover, this report provides a comparative analysis of survey results with Q1 2014 and Q4 2013 results, wherever applicable.

 Key Findings

• Overall, 38% of defense respondents state that they are operating in a stable economic environment, while 30% state that the current economic conditions are favorable
• In comparison to Q1 2014 and Q4 2013, the percentage of respondents who opted for a positive change in customer confidence observed a significant rise in Q2 2014
• Industry respondents from North America expect considerable growth in staff headcount and sales in Q2 2014 when compared to Q1 2014 and Q4 2013 results
• Improving operational efficiency and retaining customers are the most preferred priorities by defense executives operating across all regions.

 Synopsis

This report "Defense Business Confidence Report" is the result of an extensive survey drawn from Strategic Defence Intelligence's exclusive panel of leading global defense industry executives. The report analyzes current economic conditions prevailing across the globe and their impact on the defense industry, and forecasts the company and industry growth prospects over the next six months. Furthermore, it provides information about the impact of customer confidence, supplier prices, and staff headcount likely to affect investment decisions in the industry over the next six months. Moreover, this report provides a comparative analysis of survey results with Q1 2014 and Q4 2013 results, wherever applicable.

 In particular, it provides an in-depth analysis of the following:

• Industry executives' opinion about the current state global economy: examines the prevailing economic conditions' and executives opinion about the global economy and the state of economy across various regions
• Growth prospects of company and industry: provides industry executives' expectation towards growth prospects of their company and the Industry over the next six months and tracks the change in executives' opinion during the last six months
• Change in customer confidence: analyzes the defense industry executives' opinion about the change in customer confidence, globally, over the next six months and a comparative analysis with last two quarter results
•  Impact of supplier prices: determines the expected change in supplier prices across various categories and their impact on business confidence and examines the key factors influencing the change
• Change in staff headcount and sales performance: tracks the expected change in staff headcount and sales among industry executives operating in various regions, over the next six months
•  Investment activities: ascertains the various investment activities on which the industry executives intend to focus on, and tracks the change priorities and strategies regarding future investments
• Business concerns: examines the industry executives' attitude towards various business concerns and their change in opinion over the last six months
• Key priorities: identifies the immediate priorities of industry executives operating in various regions, and tracks the change in executives' sentiment compared to the last quarter.

 Reasons To Buy

• The report projects the current and future operating conditions of the defense industry, and allows readers to make effective business decisions
• The report assists readers to take strategic decisions by understanding the present and future economic and consumer issues including key growth regions
• Defense suppliers will be provided with a clear uncovering of the key challenges and opportunities, and identify the key priorities likely to affect the industry's growth prospects
• The report forecasts the change in supplier prices of various products, which are likely to influence the industry's growth prospects over the next six months
• The report helps defense executives to recognize the change in customer confidence levels in the global defense industry over the next six months.

Pressure Sensitive Adhesives Market by Technology, by Application and by Geography Global Trends & Forecasts to 2018

Summary

Increasing need for weight reduction of end-user products, high bonding solutions, sustainable developments, growing tapes demand, rising GDP, purchasing power, will drive the global pressure sensitive adhesives (PSA) market to $8.4 billion by 2018. India and China leads the world in terms of usage of PSA due to heavy industrialization in these countries, which makes it the biggest market for adhesives. The market here is expected to experience highest revenue growth during the next five years.

The factors driving growth in the PSA market are rising applications, current & emerging applications, and increase in tapes and labels demand. In addition, the demand for PSA in applications such as RFID, clean room label, etc. is also high. The factors hindering the growth of this market are the fluctuating cost of raw materials, lack of technology infrastructure in developing countries, and huge investment in R&D.

The market is growing slowly in Europe and will continue to grow at significant rate in the Asia-Pacific region. Asia-Pacific regions demand is driven by the countries such as China, the fastest growing country in global PSA market. The PSA market is still in infancy stage in African markets. However, this region is experiencing high growth on account of increased infrastructure spending.

Most players in this industry are very huge and manufacture highly customized products focusing on a particular end-user industry. 3M is a leader in Pressure sensitive adhesives for tapes while Avery Dennison leads in PSA for labels. Every company, big or small, wants to penetrate deeper into the existing market and at the same time expand into new and emerging markets to increase their sales margin; thereby increasing the overall revenue. The companies involved in adhesives business adopted this strategy by expanding into emerging markets such as Asia-Pacific and Rest of World markets. Most of the major companies in the adhesives business are headquartered in the U.S. and Europe.

With the increase in demand of pressure sensitive adhesives in automotives, the tapes segment will see a rise in the future. The demand of specialty tapes for varied applications like marine, automotive, aerospace, electronics will witness a significant growth due to high capabilities of these tapes. Also, the growing health concerns among people will increase the demand for PSA for medical applications such as surgical tapes, dressing tapes, sanitary napkins, etc.

The global market is analyzed in terms of revenue ($million) for all the regions and their respective major countries. Revenues from each region have been broken down by types of material and their applications such as industrial tapes, medical tapes, specialty tapes, labels, graphics, and others. The report forecasts revenue of the global pressure sensitive adhesives market and its various submarkets with respect to five main regions such as North America, Europe & Eurasia, Asia-Pacific, Latin America, and Middle East & Africa. The countries such as U.S., China, Germany, U.K, France, Japan, and India etc. were analyzed.

For this report, various secondary sources such as chemical & material magazines, encyclopedia, directories, technical handbooks, company annual reports, industry association publications, articles, trade websites, and databases have been referred to identify and collect information useful for this extensive commercial study. The primary sources - experts from related industries and suppliers - have been interviewed to obtain and verify critical information as well as to assess the future prospects and market estimations.

Pressure sensitive adhesives market report analyzes various marketing trends and establishes the most effective growth strategy in the market. It identifies market dynamics such as drivers, restraints, opportunities, burning issues, and winning imperatives. The major companies such as BASF (Germany), Ashland (U.S.), Avery Dennison (U.S.), and 3M (U.S.) are also been profiled in this report.

Scope of the report

On the basis of geography:
North America
Europe
Asia-Pacific
Rest of the World

On the basis of applications:
Industrial Tapes
Specialty Tapes
Medical Tapes
Labels
Graphics
Others

On the basis of technology:
Water-based
Solvent-based
Hot Melt
Radiation cured

Precision Farming Market by Technology, Components, Applications

For the past few years, the amount of electronic equipment in machinery has gradually increased, as manufacturers build more functional, and with enhanced productivity and performance features in their equipment. Most of these equipment have been comprising an individual user interface mounted in the tractor, which could typically control only one specific piece of equipment. It was observed that to provide inter-operability between the electronic systems on different tractors implements and user interfaces, and standardization of the electronics were required. This led to the development of ISO 11783 standard, designed by the working group across North America.


The global precision farming market report covers the entire industry on the basis of technology, hardware & software component, application, and geography. The technology section covers different GPS and variable rate technologies, along with their current and future estimations. Of all the major technologies, variable rate technology is expected to register higher adoption rates for mass markets. The application section covers yield monitoring, variable rate application, field mapping, soil monitoring, crop scouting, and others. The applications such as variable rate applications and yield monitoring are expected to be the major revenue generators for the Global precision farming market. The geographical analysis covers Americas, Europe, APAC and ROW regions.

The major drivers for this market are augmented yield & profitability, which are the major contributing factors for farmers to go for precision farming; other drivers like energy & cost saving, and government assistance have also been contributing to the market growth. Major restraints like high initial investments, and lack of awareness and their impact analysis are also covered under this study.

The major companies involved in the global precision farming industry are Deere & Company (U.S.), Trimble Navigation Ltd. (U.S.), Raven Industries (U.S.), Precision Planting Inc. (U.S.), and AgJunction Inc. (U.S.), among others. The U.S. will remain the leading market for the Americas precision farming, throughout the forecasted period, due to their high adoption rate, financially strong growers, and continuous development.

Australia Peripheral Vascular Devices Market Outlook to 2020

"Australia Peripheral Vascular Devices Market Outlook to 2020", provides key market data on the Australia Peripheral Vascular Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories Inferior Vena Cava Filters (IVCF), Peripheral Embolic Protection Devices, Peripheral Guidewires, Peripheral Vascular Stents, PTA Balloons, PTA Peripheral Drug Eluting Balloons (DEB), Renal Denervation Disposable Catheters, Aortic Stent Grafts, Vascular Grafts and Peripheral Venous Thrombectomy Devices.

 The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Peripheral Vascular Devices market wherever available.

 The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipmentbased models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

 The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

 Capital equipmentbased forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

 Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
 
 Scope

 - Market size for Peripheral Vascular Devices categories Inferior Vena Cava Filters (IVCF), Peripheral Embolic Protection Devices, Peripheral Guidewires, Peripheral Vascular Stents, PTA Balloons, PTA Peripheral Drug Eluting Balloons (DEB), Aortic Stent Grafts, Vascular Grafts and Peripheral Venous Thrombectomy Devices.
 - Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
 - 2012 company shares and distribution shares data for the market category.
 - Global corporate-level profiles of key companies operating within the Australia Peripheral Vascular Devices market.
 - Key players covered include C.R. Bard, Inc., Abbott Laboratories, Boston Scientific Corporation, Cordis Corporation, Medtronic, Inc. and Covidien plc.

 Reasons to buy

 - Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
 - Develop market-entry and market expansion strategies.
 - Design competition strategies by identifying who-stands-where in the market.
 - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
 - What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.

Travel and Tourism in Indonesia to 2018

Synopsis

The "Travel and Tourism in Indonesia" report provides detailed market analysis, information and insights, including:

Historic and forecast tourist volumes covering the entire Indonesian travel and tourism sector

Detailed analysis of tourist spending patterns in Indonesia for various categories in the travel and tourism sector, such as accommodation, sightseeing and entertainment, foodservice, transportation, retail, travel intermediaries and others

Detailed market classification across each category, with analysis using similar metrics 

Detailed analysis of the airline, hotel, car rental and travel intermediaries industries

Summary

The Indonesian travel and tourism sector recorded growth during the review period (20092013). Domestic tourist volumes reached 252.4 million in 2013, while international tourist volumes reached 8.8 million, driven by tourists from countries such as Singapore, Malaysia, Australia, China, and Japan. Forecast-period (20142018) growth is expected to be supported by government initiatives promoting new tourism destinations.

Scope

This report provides an extensive analysis related to the tourism demands and flows in Indonesia: 

It details historical values for the Indonesian tourism sector for 20092013, along with forecast figures for 20142018

It provides comprehensive analysis of travel and tourism demand factors, with values for both the 20092013 review period and the 20142018 forecast period

The report provides a detailed analysis and forecast of domestic, inbound and outbound tourist flows in Indonesia.

It provides comprehensive analysis of the trends in the airline, hotel, car rental and travel intermediaries industries, with values for both the 20092013 review period and the 20142018 forecast period

Reasons To Buy

Take strategic business decisions using historic and forecast market data related to the Indonesian travel and tourism sector.

Understand the demand-side dynamics within the Indonesian travel and tourism sector, along with key market trends and growth opportunities.

Key Highlights

As domestic tourists are dependent on air travel within the Indonesian archipelago, the number of domestic air travelers is expected to record significant growth in 2014. In total, 12 new airports were built in 2013 and a further 12 are planned for development by 2015. The expansion of new routes by domestic carriers has provided more opportunities for domestic tourism and has opened up locations such as Belitung, Bandung, Pangkalpinang, Mataram, Bali, Tarakan, Pontianak, Malang and Batu, Bandar Lampung and Labuan Bajo to more frequent visits.

Garuda Indonesia launched flights to many destinations in Eastern Indonesia using smaller aircraft. Garuda is currently flying from Bali to Komodo Airport at Labuan Bajo in Flores, from Denpasar to Labuan Bajo and Tambolaka, from Denpasar to Bima and Mataram in West Nusatenggara, Denpasar to Mataram and Bima routes starting December 2013. In November 2013, Garuda Indonesia began providing immigration services for its passengers on its GuangzhouJakarta flights.

According to the Indonesian Hotel and Restaurant Association (PHRI), at least 45,000 new hotel rooms will open in 2013, an addition of 30,000 rooms, compared to 15,000 in 2012. Around 36 budget and upscale hotels were launched in 2013 in Jakarta, adding 3,000 new rooms. Popular hotel brands such as Ibis Budget, Pop! Hotel, Favehotel, Amaris, Tune and Whiz are constructing budget hotels primarily in Menteng, Kebayoran Baru, Setiabudi, Thamrin and Kemang. Indonesias largest travel and tour companies Panorama and Cipaganti plan to inaugurate 10 new properties each in 2014 and 2020 respectively. Panoramas projects will range from budget to upscale hotels in Java and Bali, while Cipaganti will build hospitality and apartment properties.

Indonesias car rental market is still in a development phase. Excluding major cities, renting a car is not a common practice for domestic tourists. Upper- and upper-middle-income families use their own cars, while middle- and lower-income families generally use trains or buses as they are cheaper. Leisure car rentals accounted for 57.1% of the markets total value in 2013, and expected to increase at a CAGR of 6.98% over the forecast period.

Many Indonesian travel intermediaries use a computerized reserved system (CRS) provided by PT Abacus Indonesia, a joint venture of Garuda Indonesia and Abacus Singapore. The CRS provides information about tour packages, hotel chains and car rental agencies operating across the world. It provides fast and accurate information to customers about hotels, tickets and tour package reservations.

The Future of the Fish and Seafood Market in the United Kingdom to 2018

Summary

The Future of the Fish & Seafood Market in the United Kingdom to 2018 is the result of Canadeans extensive market research. The report presents detailed analysis on the Fish & Seafood consumption trends in the United Kingdom, historic and forecast Fish & Seafood consumption volumes and values at market and category level, brand share and distribution channel data. This report brings together Canadean Intelligences research, modeling and analysis expertise in order to develop uniquely detailed market data. This allows domestic and foreign companies to identify the market dynamics to account for Fish & Seafood sales overall and to know which categories and segments are showing growth in the coming years.
 
Key Findings

Why was the report written?
This report provides authoritative and granular data on the Fish & Seafood market in the United Kingdom and, in doing so fills the gaps in marketers understanding of trends and the components of change behind them.
Based upon extensive primary and secondary research to provide comprehensive and granular data, this report allows marketers to confidently update their strategic and tactical plans.
Marketers need data on volume and value changes, brand dynamics and distribution trends in order to effectively plan strategies.

What are the key drivers behind recent market changes?
This report examines the components of change in the market by looking at historic and future growth patterns, including the effects of consumers behavior on total volumes, values, brands selected and types of product chosen.

What makes this report unique and essential to read?
The report provides the latest, detailed data on dynamics in the United Kingdom Fish & Seafood market, providing marketers with the essential data to understand their own, and their competitors position in the market and the information to accurately identify where to compete in the future.

Synopsis

Detailed category coverage is provided, covering six product segments that include: Ambient Fish & Seafood, Chilled Raw Packaged Fish & Seafood - Processed, Chilled Raw Packaged Fish & Seafood - Whole Cuts, Dried Fish & Seafood, Fresh Fish & Seafood (Counter), Frozen Fish & Seafood.
Detailed product sales segmentation (for both volumes and values) is provided, including brand data, and sales by distribution channel, at the product category level.

Future forecasts allow marketers to understand the future pattern of market trends from winners and losers to category dynamics and thereby quickly and easily identify the key areas in which they want to compete in the future.

Cyber Security Market

Cyber security ensures realization and controlling of security properties of an organizations as well as users intellectual and financial assets against relevant security risks in the cyber environment. With the ascending growth and sophistication of cyber attacks in the last few years, strict compliance and unified security packages are in demand to protect the huge confidential data of government, military, public utilities, Banking, Financial Services and Insurance (BFSI), hospitals and other businesses. In context to this, security solutions such as data encryption, Security and vulnerability management, Distributed Denial of Service (DDoS) mitigation, web filtering, next generation firewalls are being used for data privacy and creating an alignment between business strategy and security solution portfolios.

The growing number of mobile workforce, in support of trends like Bring Your Own Device (BYOD), blooming cloud-based services and Advanced Persistent Threats (APTs) present a comprehensive opportunity for research and development in cyber security products and services portfolio. Apart from these, factors such as need for unified cyber solutions, strict compliance and data disclosure mandates, risk over maintenance of sensitive data, enhanced enterprise mobility, and increasing spending pattern on security forums are boosting up the demand for cyber security solutions. It is expected that the cyber market will show enormous growth with credence in the coming years. Major players in the cyber security ecosystem include Booz Allen Hamilton, Cisco, CSC, IBM, Lockheed Martin, McAfee, Microsoft, Northrop Grumman, Symantec and Trend Micro.

The report on cyber security market majorly focuses on estimation of current market size and future growth potential across all the major segments of this market, i.e., types, solutions, services, verticals, and regions. Furthermore, the report also includes an extensive analysis of the key players in the cyber security space with their profiles, strategy and developments, major market drivers, restraints, opportunities, challenges, global adoption trends, and key issues in the market.

Scope of the Report

This research report "Cyber-Security Market: Advanced Technologies, Geographical Analysis and Worldwide Market Forecasts (2012 2017)" categorizes the global cyber security market to forecast the revenues and analyze the trends in each of the following submarkets:

On the basis of cyber security market by types:

Network security
Endpoint security
Application security
Content security
Wireless security
Cloud security

On the basis of cyber security market by solutions:

Identity and access management
Risk and compliance management
Encryption
Data loss protection
Unified threat management
Firewall
Antivirus and anti malware
IDS/IPS
Security and vulnerability management
Disaster recovery
DDoS mitigation
Web filtering
Others

On the basis of cyber security market by services:

Consulting
Design and Integration
Risk and Threat assessment
Managed security service
Training and Education

On the basis of cyber security market by industry verticals:

Aerospace, Defense and Intelligence
Government (excluding defense) & Public Utilities
Telecom & IT
BFSI
Healthcare
Retail
Manufacturing
Others

On the basis of cyber security market segmentation by regions:

North America
Europe
Asia-Pacific
Middle East and Africa
Latin America

OpportunityAnalyzer

Uveitis is an expanding market currently dominated by corticosteroid treatment options as well as off-label immuno-suppressive and biologic drugs. Since the conventional corticosteroid treatment is only effective in 50-60% of patients a significant number of patients can be targeted with the new treatment options. While anterior uveitis patients represent the majority of patients, all but one of the new treatments in late stage clinical development target the intermediate, posterior and pan uveitis patient segment. The uveitis market is expected to grow between 2012 and 2017, due to the introduction of biologic drugs as well as a diversification of administrative routes. Market growth is created by the increase in treatment costs and will continue beyond the forecasted time period. The new treatments will target some key unmet needs but opportunities will remain for drugs capable of permanently inhibiting ocular inflammation as well as offering an improved safety profile.

Highlights


Key Questions Answered

- The uveitis market is marked by the presence of a number of unmet needs in current treatments. What are the main unmet needs in this market? Will the drugs under development fulfil the unmet needs of the uveitis market?
- The late-stage uveitis pipeline is filled with diverse molecules and routes of administration. Which drug will have a significant impact on the uveitis market. Which of these drugs will have the highest CAGR, and why?
- The current uveitis market is dominated by corticosteroids as well as off-label immunosuppressive and biologic drugs. How will the introduction of biologic drugs change the treatment landscape once reimbursement is not a problem anymore? How will the drug treatment rates change over the next five years? What are the key drivers and barriers to this change?

Key Findings

- The main driver of the expansion of the uveitis market will be the introduction of biologic drugs, which will increase the market size significantly. The introduction of new ocular administration routes will strengthen the market growth further.
- An additional driver for the uveitis market is the assignment of orphan drug status to several uveitis drugs.
- The biggest barrier for the introduction of the more costly treatment options like biologics will be reimbursement especially in the European markets. To ensure reimbursement companies will have to work closely together with payers and price their drugs competitively.
- Pipeline drugs developed by small to mid-size pharma companies represent a good opportunity for companies to enter the uveitis market and to strengthen their ophthalmology department.

Scope of the "OpportunityAnalyzer: Uveitis Opportunity Analysis and Forecasts to 2017" Report :

- Overview of uveitis, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines.
- Annualized uveitis therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2012 and forecast for five years to 2017.
- Key topics covered include market characterization, unmet needs, R&D and clinical trials assessment, late stage clinical trial analysis and implications for the uveitis therapeutics market.
- Pipeline analysis: focus on the five late-stage pipeline drugs discussing emerging trends as well as overview of earlier phase drugs.
- Analysis of the current and future market competition in the global uveitis therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. Additionally a list of acquisition targets included in the pipeline product company list.
- Develop business strategies by understanding the trends shaping and driving the global uveitis therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global uveitis therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track drug sales in the global uveitis therapeutics market from 2012-2017.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Xalkori (Non-Small Cell Lung Cancer)

Summary

 "Xalkori (Non-Small Cell Lung Cancer) - Forecast and Market Analysis to 2022"
Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of targeted therapies for patients with specific biomarkers has begun to fragment the NSCLC treatment landscape into smaller niche patient populations. Over the forecast period, this trend will continue with the launch of multiple new drugs in several new drug classes to address the high unmet need among NSCLC patients, and provide new treatment options for previously underserved populations. Launch of premium-priced drug candidates combined with increasing incident cases of the disease will be major drivers of growth in the major markets.

Pfizers twice-daily oral tablet, Xalkori, is indicated in the US for the treatment of ALK-positive NSCLC patients, as determined by an FDA-approved companion diagnostic. Xalkori has received conditional marketing authorization in the EU for use in ALK-positive patients, and determination of ALK status is required by any appropriate means.

Scope

- Overview of NSCLC, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on Xalkori including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for Xalkori for the top nine countries from 2012 to 2022.
- Sales information covered for the US, France, Germany, Italy, Spain, the UK, Japan, India and China.

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of the competition by understanding the changing competitive landscape for NSCLC
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of Xalkori performance
- Obtain sales forecast for Xalkori from 2012-2022 in top nine countries (the US, France, Germany, Italy, Spain, the UK, Japan, India and China)

Vaccine Market - By Technology & Types, Infectious Diseases

The vaccine market is an established segment and is widely accepted as an indispensable division of the healthcare industry. It is poised to grow rapidly by addressing the following: emerging infectious agents, various types of cancer, allergies, cardiovascular diseases, diabetes, smoke cessation, and neurodegenerative disorders. The global vaccine market is estimated at $32.05 billion in 2013 and is expected to reach $84.44 billion by 2022.

In general, the vaccine market is largely perceived negatively as a low-profit venture owing to the domination of top five companies, namely, Sanofi (France), Glaxo Smithkline (U.K.), Merck (U.S.), Pfizer (U.S.), and Novartis (Switzerland). Furthermore, a strong patent portfolio and the need for large investments towards vaccine development have limited the scope of entry for new companies.

The vaccine market is analyzed both in terms of qualitative (technological) and quantitative (revenue) perspectives. The technological analysis includes a discussion on different classes of vaccines, vaccine adjuvants, and commercially available products. The market revenue analysis includes market segmentation and the expected market position by 2022, with the projected growth rate.

The vaccine market is classified by technology class, types, end users, disease indication, and geography. The details on the emerging approaches to vaccine development such as reverse vaccinology, personalized vaccinomics, and systems vaccinomics are discussed. Furthermore, key research centers, with their critical areas of research in the vaccine space, have been provided.

An overview of regulations across various geographical regions has been covered. The complete value chain of the vaccine market is schematically represented and the significance of each stakeholder has been briefed.

Apart from the technological and market analysis, the investor climate has been assessed by tracking the complete investor network and collecting data on funds/grants and investments made towards vaccine development. Insights on current and future technological investment trends have also been discussed.

A large number of potential therapeutic and preventive vaccine candidates addressing various diseases which are in the pipeline are listed with their current status in clinical trials.

The adoption and developmental potential of the vaccine technology market has been discussed on a geographic basis, namely, North America, Europe, Asia, and the Rest of the World, by taking select countries that are poised to have a greater market value during the forecast period.


In brief, this research report provides:

A detailed description of the global technology developments and evolving trends in the vaccine field with key prominence on research innovations, collaborative efforts, and investments for vaccines.
A close view on the therapeutic vaccines for various diseases by providing details and status of current vaccines in the pipeline.
An impact analysis of the major drivers and restraints influencing the adoption and growth of the vaccine market during the period of 2013 to 2022.
Porters five forces analysis and GAP analysis.
The global market forecast for 2013 - 2022, including demand side analysis and strategic recommendations for technology/product developers.
Competitive landscape tracking industry activities such as mergers, acquisitions, partnerships, collaborations, and strategic agreements within the vaccine market. Intellectual property strength analysis based on the number of patents filed by the top five players within the vaccine market that gives an insight into prominent activities and global leaders of the industry.

Scope of the Report

This research report categorizes the global vaccine market into technology class, types, end users, disease indication, and geography. Each segment is further broken down by geography, with exhaustive revenue analysis for 2012 and 2013, as well as the forecast up to 2022.

Global Vaccine Market, by Technology Class

Live
Toxoid
Conjugate
Sub-Unit
Recombinant Vector Vaccines
DNA Vaccines
Synthetic Vaccines
Dentritic Vaccines

Global Vaccine Market, by Types

Preventive
Therapeutic

Global Vaccine Market, by End Users

Pediatric
Adult

Global Vaccine Market, by Disease Indication

Infectious Diseases
Cancer
Allergies
Others

Global Vaccine Market, by Geography

North America
Europe
Asia-Pacific
Rest of the World (RoW)

Food and Grocery Retailing in China

Summary

Food and Grocery Retailing in China - Market Summary
and Forecasts, report, published by Conlumino, provides a detailed analysis of both the historic and forecast market data of food and grocery retail sales across key channels in China. In addition, it provides an overview of changing shopping trends, government policies towards business, the influence of various economic variables on the retail industry, the competitive landscape and detail of key retailers.

Key Findings
- Strong economic growth and the move to become a consumer led economy will be just one factor driving significant growth in Chinese retail sales to 2018.
- Greater access and availability of products will drive further growth of retail.
- A changing shopping mode- from functional, deal driven to emotional, status driven, is creating new
- The food and grocery segment will continue to be dominated by local players.

Synopsis

- Food and Grocery Retailing in China - Market Summary
and Forecasts is a detailed sector report providing comprehensive analysis of the emerging trends, forecasts and opportunities in Chinas food and grocery retail market
- The report is a result of a thorough analysis of consumer trends, and changing economic and population factors of the country.
- The report provides both qualitative and quantitative insights of the changing food and grocery retail dynamics across 17 retail channels and 5 product categories.
- It provides an overview of key retailers operating across the product segment and their presence across channels

ReasonsToBuy
- The report provides a comprehensive overview of the Chinese food and grocery retail market for companies already operating in and those wishing to enter the Chinese market.
- Understand which channels will be the major winners and losers over the coming years and plan accordingly, with a comprehensive coverage covering 5 product categories that include: Drinks, Household products, Packaged food, Tobacco and Unpackaged food
- Benefit from a detailed analysis of vital economic and population trends and key consumer trends influencing the retail market.
- Monitor the competitive landscape with the analysis of key international and domestic players in food and grocery market.

Brazils Mining Fiscal Regime

Synopsis
Brazil mining fiscal regime report outlines governing bodies, governing laws, mining licenses, rights and obligations and key fiscal terms covering 13 commodities: coal, iron ore, copper, zinc, bauxite, gold, lead, silver, chromium, nickel, platinum, uranium and manganese

Summary
The mining industry in Brazil is governed by the Ministry of Mines and Energy (MME) and the Brazil Geological Survey (CPRM). The Mining Code of 1967 regulates all exploration and extraction activities of minerals in Brazil. The code specifies deposits and mines, and sets rules and regulations for authorization, concession, licensing and permits, and plans the duties of holders of mining rights and regulating authorities, among others.

Scope
The report outlines Brazils governing bodies, governing laws, mining licenses, rights and obligations and key fiscal terms which includes Royalty, Corporate Income Tax, Land Owner Royalty, Annual Tax, Withholding Tax, Depreciation and VAT.

Reasons To Buy
To get an overview of Brazils mining fiscal regime.

Key Highlights
The mining industry in Brazil is governed by the Ministry of Mines and Energy (MME) and the Brazil Geological Survey (CPRM). The Mining Code of 1967 regulates all exploration and extraction activities of minerals in Brazil.
The MME came into existence in 1960. It is an apex body for the formulation and administration of regulations relating to the mining and energy industries resources.
The DNPM is a federal agency and report to the MME. The department was incorporated in 1934 and became an independent self-regulatory institution in 1994. It focuses on the planning and promotion of mineral exploration, and supervises geological and mineral technology.
The CPRM is a federal government organization under the jurisdiction of the Ministry of Mines and Energy. It was established in 1969, and became an entirely state-owned institution in 1994. 

Nuclear Medicine Market and Radiopharmaceuticals

The report focuses on "Nuclear Medicine Market and  Radiopharmaceuticals [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha radiation therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & Stable Isotopes (Deuterium, C-13) - Global Trends & Forecast to 2017"

The market of radiopharmaceuticals is dominated by diagnostic radioisotopes, comprising of SPECT and PET radioisotopes. The lion’s share of the SPECT market is taken up by Tc-99m, whereas the PET market is dominated by F-18FDG isotope. Furthermore, the PET market will witness a double digit growth during the forecast period. The therapeutic segment contributes only 10% to the global radiopharmaceuticals market and I-131 has been considered as the gold standard for various oncology treatments in a combined therapy. Global nuclear medicines market is majorly driven by the increasing adoption of PET and SPECT scanners, and rising awareness for radiopharmaceuticals, whereas short half life of isotopes and stringent regulations are the factors that are hindering the growth of radiopharmaceuticals worldwide.

Besides highly preferred isotopes such as Tc-99m and F-18, significant growth is witnessed for Tl-201 and Rb-82 in diagnostic market and Y-90 and Lu-177 in beta therapy radioisotopes market. Exhaustive pipeline analysis reveals that coronary heart disease, Alzheimer’s disease, breast cancer, and bone metastasis will drive the diagnostic radiopharmaceuticals market, whereas lymphoma, prostate cancer, bone metastasis, and hepatocellular carcinoma will boost the future of therapeutic radiopharmaceuticals. Besides new applications, the potential molecules that are expected to drive the market include Alpharadin (Ra-223), Ga-68, F-18 florbetapir, and F-18 choline. Though Ra-223 application is still under clinical trial, the market is highly optimistic regarding its clinical efficiency in prostate cancer, and bone metastasis.

North America held the largest share in the global radiopharmaceuticals market. The U.S. market is highly supported by the Mo-99 production of NRU reactor (Canada) and ongoing researches in different clinical institutes such as National Cancer Institute, Avid Radiopharmaceuticals and so on. Besides developed markets, the Asia-Pacific region is expected to show a remarkable growth in the coming years. China, India, Japan, South Korea, Brazil, and South Africa are expected to show a high growth potential amongst the emerging geographies. These countries are influenced by the domestic production of isotopes by reactors and government initiatives.

Apart from upcoming isotopes and their applications, understanding of the interlinked supply chain was imperative for market estimation. Value chain analysis and pipeline analysis have taken care of such business issues to come up with a consolidated market analysis, including the present and future impact of different factors. Demand and supply analysis identifies the potential risk of the interrupted supply of Mo-99 for the Tc-99m production, due to scheduled shutdown of major reactors and the benchmarking trend adopted by leading players to combat such operational difficulties.

The radiopharmaceutical market has been analyzed from both the radiopharmaceuticals processors’ and generator manufacturer’s perspectives. It has been identified that shifting from HEU to LEU is the major strategy in the processors market, while strengthening the supply chain of radiopharmaceuticals is the prime concern for the generator manufacturers.

In addition to the market size and forecast for radioisotopes, the report also covers competitive landscape and key developments of major players, pipeline analysis, investment opportunities, and regulatory affairs for established players as well as new entrants.

Winning and Retaining Business in the Australian Mining Equipment Sector

Synopsis
The survey primarily assessed heavy mobile equipment, however respondents were also asked about their practices and preferences in areas such as mining software, technology, and maintenance.
Areas of analysis include:
Customer priorities when buying mining equipment, with ratings of the importance of 16 separate factors for customers when choosing mining equipment, including cost factors, supplier attributes and product attributes.
Ratings of existing suppliers across the same factors, identifying best-performing suppliers and how well suppliers performed versus the importance of each factor.
In-depth analysis of the major suppliers, namely Caterpillar, Joy Global, Komatsu and Volvo, including their overall performance ratings and their ratings for each of the factors relative to its importance.
Rankings of the leading suppliers for each equipment type, with respondents indicating who they viewed as the top suppliers in Australia for trucks, excavators, loaders, shovels, dozers, drills, continuous miners, longwall systems, engines, tyres, pumps and mining software.
Insight into the likelihood of switching supplier and key action points for suppliers for product and service improvements required.

Summary
Overall trends in the data revealed:
- Customer priorities in supplier selection are product quality and availability of parts
- Suppliers perform well, but customer satisfaction is frequently lowest in the most important areas for customers
- Volvo and Komatsu received the highest average satisfaction ratings, with Caterpillar considered the leading supplier for most categories of mining equipment
- Account managers make a significant impact in the selection process
- Although loyal to their suppliers, customers look for improvement in parts availability and product quality

Scope
Winning and Retaining Business in the Australian Mining Equipment Sector, 2014 published by Timetric Mining Intelligence Centre, provides readers with a detailed analysis of customer preferences in the Australian mining sector. The analysis is based upon Timetrics survey of 110 mine managers, procurement managers and other key decision-makers

Reasons To Buy
Identify key areas for differentiation by understanding what factors most influence choice of supplier.
Target product and service improvement areas based on where mining equipment suppliers are currently underperforming relative to customer expectations.
Develop successful sales and marketing strategies through an understanding of the leading competitors and their strengths and weaknesses.

Key Highlights
When choosing an equipment supplier, respondents rate Production reliability and quality and the Availability of replacement parts as most important. However, over half of respondents feel that suppliers need to improve in the latter.
Overall the major suppliers perform well in terms of customer satisfaction, however, their weakest ratings were given for two of the three most important factors for respondents.
Account managers make a significant impact in the selection process with 77% of respondents citing Better understanding of your needs and 81% indicating Better ability to build a long-term relationship as differentiating factors when choosing their current main supplier.
There was a greater likelihood for respondents to switch supplier where satisfaction was low. While on average 7% plan to switch supplier within the next five years, this percentage is much higher for respondents whose satisfaction scores were below average.
Although most are loyal to their suppliers, customers are specifically looking for improvements in parts availability, product quality and the ability to support cost reductions.

Wearable Technologies in Clothing

The convergence of digital technology and apparel represents a huge opportunity as the telecom, electronics, clothing, and accessories industries cooperate to bring wearable technology to the consumer in a very personal way. While some wearable technology examples represent trendy fashion statements, others bring more than form as high function becomes a reality, particularly in the health and fitness sub-segment.

We see certain wearable technologies in clothing as fully integrated, stand-alone offerings while others are enablers of others such as sensors. Wearable sensors must be flexible, durable, multifunctional and washable to be used in clothing. Most wearable sensors made of pouring a liquid polymer insulator over nanowires attached to a silicon plate. Sensors get integrated into clothing or can be in direct contact with the human skin.

This research evaluates wearable technology in clothing including current offerings, anticipated future solutions, and the overall industry outlook. The report also provides forecasting for 2015 to 2020.

Target Audience:

Telecom companies

Semiconductor companies

Health and fitness industry

Clothing and accessory industry

Wearable technology companies